Table 1.
Correlation between expression of POTEE and clinical characteristics of CRC patients
| Characteristics | Cases | POTEE Immunostaining | χ2 value | P | |
|---|---|---|---|---|---|
| Decreased expression | High expression | ||||
| Gender | 0.200 | 0.655 | |||
| Male | 42 | 16 (38.1%) | 26 (61.9%) | ||
| Female | 39 | 13 (33.3%) | 26 (66.7%) | ||
| Age (years) | 1.454 | 0.228 | |||
| <60 | 32 | 14 (43.8%) | 18 (56.3%) | ||
| ≥60 | 49 | 15 (30.6%) | 34 (59.4%) | ||
| Lymph nodal metastasis | 4.464 | 0.029 | |||
| N0 | 49 | 22 (44.8%) | 27 (45.2%) | ||
| N1/N2 | 32 | 7 (21.8%) | 25 (78.1%) | ||
| TNM | 5.901 | 0.013 | |||
| I/II | 47 | 22 (46.8%) | 25 (53.2%) | ||
| III/IV | 34 | 7 (20.6%) | 27 (79.4%) | ||
| Tumor sizea | 4.500 | 0.042 | |||
| <5 cm | 46 | 21 (45.7%) | 25 (54.3%) | ||
| ≥5 cm | 34 | 8 (23.5%) | 26 (76.5%) | ||
a1cases missing Tumor size data